These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6700099)

  • 21. Are many women immunized against rubella unnecessarily?
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Mace JE; Hutchinson A
    J Hyg (Lond); 1981 Aug; 87(1):131-8. PubMed ID: 7019319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selective and controlled mass rubella vaccination - experiences with an economical method (author's transl)].
    Zippel C; Federmann G; Leidel J; Eggers HJ
    Immun Infekt; 1982 Mar; 10(2):69-75. PubMed ID: 7040210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme linked immunosorbent assay of rubella antibody.
    Kikuchi T; Kuno-Sakai H; Kimura M
    Tokai J Exp Clin Med; 1983 Jul; 8(3):275-9. PubMed ID: 6367150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failed rubella immunization in adults: association with immunologic and virological abnormalities.
    Tingle AJ; Chantler JK; Kettyls GD; Larke RP; Schulzer M
    J Infect Dis; 1985 Feb; 151(2):330-6. PubMed ID: 3968452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive neutralization test for rubella antibody.
    Sato H; Albrecht P; Krugman S; Ennis FA
    J Clin Microbiol; 1979 Feb; 9(2):259-65. PubMed ID: 107192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Directed immunization of female employees in the health services and schools using live rubella vaccine strain RA 27/3 on the basis of a screening test with radial hemolysis].
    Strauss J; Mrázová M; Macátová I; Růzicka E
    Cesk Epidemiol Mikrobiol Imunol; 1987 Oct; 36(5):271-9. PubMed ID: 2959379
    [No Abstract]   [Full Text] [Related]  

  • 32. Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands.
    Chu SY; Bernier RH; Stewart JA; Herrmann KL; Greenspan JR; Henderson AK; Liang AP
    JAMA; 1988 Jun; 259(21):3133-6. PubMed ID: 3367488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Seroimmunity against rubella 5 years after immunisation with Cendehill vaccine (author's transl)].
    Sarateanu DE; Ehrengut W
    Immun Infekt; 1975 Apr; 3(2):51-3. PubMed ID: 1184096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests.
    Storch GA; Myers N
    J Infect Dis; 1984 Mar; 149(3):459-64. PubMed ID: 6371155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.
    Mitchell LA; Zhang T; Ho M; Décarie D; Tingle AJ; Zrein M; Lacroix M
    J Clin Microbiol; 1992 Jul; 30(7):1841-7. PubMed ID: 1629342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rubella-antibodies in school children.
    LaBianca T; LaBianca J; Ibsen KK
    Dan Med Bull; 1985 Oct; 32(5):267-9. PubMed ID: 4053697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to experimental challenge in persons immunized with different rubella vaccines.
    Fogel A; Gerichter CB; Barnea B; Handsher R; Heeger E
    J Pediatr; 1978 Jan; 92(1):26-9. PubMed ID: 619075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.